CureDiab at ECM Pharmacology Congress

10. April 2024

From 17th-19th of June we will join the extracellular matrix pharmacology congress to support rapid diffusion of acquired knowledge across drug development. Thus, we will present our discovery about the antifibrotic activity of positive allosteric modulators of the GABA-A receptor. We are looking forward to join interesting talks and discuss about the latest updates on drug development, liver interaction and fibro-inflammation. Do not hesitate to contact us and meet us there.